Oral N-acetylcysteine: how does it act?
Richardson, P.
European Journal of Respiratory Diseases 70(2): 71-72
1987
ISSN/ISBN: 0106-4339 PMID: 3817073 Document Number: 292197
Document emailed within 1 workday
Related Documents
Holoye, P.Y.; Duelge, J.; Hansen, R.M.; Ritch, P.S.; Anderson, T. 1983: Prophylaxis of ifosfamide toxicity with oral acetylcysteine Seminars in Oncology 10(1 Suppl 1: 66-71Götz, M.; Kraemer, R.; Kerrebijn, K.F.; Popow, C. 1980: Oral acetylcysteine in cystic fibrosis. a co-operative study European Journal of Respiratory Diseases. Suppl 111: 122-126
De Caro, L.; Ghizzi, A.; Costa, R.; Longo, A.; Ventresca, G.P.; Lodola, E. 1989: Pharmacokinetics and bioavailability of oral acetylcysteine in healthy volunteers Arzneimittel-Forschung 39(3): 382-386
Brocard, H.; Charpin, J.; Germouty, J. 1980: Multicenter, double-blind study of oral acetylcysteine vs. placebo European Journal of Respiratory Diseases. Suppl 111: 65-69
Biscatti, G.; Bruschelli, M.; Damonte, G.; Capozzi, F. 1972: Controlled studies of the clinical effects of acetylcysteine in oral administration in respiratory infections in pediatrics Minerva Pediatrica 24(26): 1075-1084
Saiers, J.H.; Slavik, M. 1981: Pilot study of intravenous ifosfamide plus oral acetylcysteine in the treatment of non-small cell lung cancer Veterinary and Human Toxicology 23(Suppl 1): 12-14
Hoshino, A.; Enomoto, S.; Kawahito, H.; Kurata, H.; Nakahara, Y.; Nakamura, T. 2007: Prevention of contrast-induced nephropathy using cardiac catheterization combined with hydration, oral N-acetylcysteine, sodium bicarbonate and iso-osmolar contrast agents Journal of Cardiology 50(2): 119-126
Taéron, C. 2010: N-Acetylcysteine Revue de l'Infirmiere 160: 47-49
Köhler, D. 1996: Acetylcysteine Deutsche Medizinische Wochenschrift 121(49): 1550
Pedersen, B.; Brøns, M.; Clausen, P.P.; Holm, K.; Petersen, D. 1986: The value of acetylcysteine in the collection of sputum Ugeskrift for Laeger 148(24): 1463-1465
Chinouth, R.W.; Czajka, P.A.; Peterson, R.G. 1980: N-acetylcysteine adsorption by activated charcoal Veterinary and Human Toxicology 22(6): 392-394
Johnston, R.E.; Hawkins, H.C.; Weikel, J.H. 1983: The toxicity of N-acetylcysteine in laboratory animals Seminars in Oncology 10(1 Suppl 1: 17-24
Balderramo, D.C. 2006: N-acetylcysteine and contrast-induced nephropathy New England Journal of Medicine 355(14): 1498-1499; Author Reply 1499-1500
Dekhuijzen, P.N.R. 2006: Acetylcysteine in the treatment of severe COPD Nederlands Tijdschrift Voor Geneeskunde 150(22): 1222-1226
Wolak, A.; Cafri, C.; Zahger, D. 2006: N-acetylcysteine and contrast-induced nephropathy New England Journal of Medicine 355(14): 1498; Author Reply 1499-1500
St Omer, V.V.; McKnight, E.D. 1980: Acetylcysteine for treatment of acetaminophen toxicosis in the cat Journal of the American Veterinary Medical Association 176(9): 911-913
Guerrero, C.A.; Torres, D.P.; García, L.L.; Guerrero, R.A.; Acosta, O. 2014: N-Acetylcysteine treatment of rotavirus-associated diarrhea in children PharmacoTherapy 34(11): E333-E340
Sarici, S.U.; Sahin, M.; Yurdakök, M. 2003: Topical N-acetylcysteine treatment in neonatal ichthyosis Turkish Journal of Pediatrics 45(3): 245-247
Olson, R.D.; Stroo, W.E.; Boerth, R.C. 1983: Influence of N-acetylcysteine on the antitumor activity of doxorubicin Seminars in Oncology 10(1 Suppl 1: 29-34
Breuer, D.; Becker, M. 1983: Acetylcysteine (Fluimucil) in the treatment of COPD of the horse Tierarztliche Praxis 11(2): 209-212